dc.contributor.author |
Choi, Hyon |
en |
dc.contributor.author |
Neogi, Tuhina |
en |
dc.contributor.author |
Stamp, Lisa |
en |
dc.contributor.author |
Dalbeth, Nicola |
en |
dc.contributor.author |
Terkeltaub, Robert |
en |
dc.date.accessioned |
2019-11-05T21:22:22Z |
en |
dc.date.issued |
2019-11 |
en |
dc.identifier.issn |
2326-5191 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/48861 |
en |
dc.format.medium |
Print-Electronic |
en |
dc.language |
eng |
en |
dc.relation.ispartofseries |
Arthritis & rheumatology (Hoboken, N.J.) |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
Humans |
en |
dc.subject |
Gout |
en |
dc.subject |
Allopurinol |
en |
dc.subject |
Rheumatology |
en |
dc.subject |
United States Food and Drug Administration |
en |
dc.subject |
United States |
en |
dc.subject |
Febuxostat |
en |
dc.title |
Reply. |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1002/art.41065 |
en |
pubs.issue |
11 |
en |
pubs.begin-page |
1967 |
en |
pubs.volume |
71 |
en |
dc.rights.holder |
Copyright: The author |
en |
pubs.end-page |
1968 |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Letter |
en |
pubs.subtype |
Comment |
en |
pubs.elements-id |
783512 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
School of Medicine |
en |
pubs.org-id |
Medicine Department |
en |
dc.identifier.eissn |
2326-5205 |
en |
pubs.record-created-at-source-date |
2019-08-06 |
en |
pubs.dimensions-id |
31379125 |
en |